Scinai Immunotherapeutics LT
13F holders, Q3 2025 (September 30)6holders
2new positions
2sold out
1famous investor
$1.26avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Scinai Immunotherapeutics LT in their 13F filings, unchanged from Q2 2025. 2 opened new positions and 2 sold out. The largest holders were Citadel Advisors ($36K), Two Sigma Securities, LLC ($19K) and Rhumbline Advisers ($4K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Scinai Immunotherapeutics LT
- CUSIP
- 09073Q303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $20K |
| Exits | 2 | $119K |
All 13F filers, Q2 2025 → Q3 2025: 32,797 shares bought and 64,058 shares sold, net −31,261 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Citadel Advisors | 0.00% | Add +146.8% | 28,630 | $36K |
| Two Sigma Securities, LLC | 0.00% | New | 14,696 | $19K |
| Rhumbline Advisers | 0.00% | Add +2.0% | 3,553 | $4K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 1,000 | $1K |
| Morgan Stanley | 0.00% | Reduce -3.9% | 245 | $310 |
| UBS Group AG | 0.00% | Reduce -99.9% | 8 | $10 |
"% of holder's portfolio" is SCINAI IMMUNOTHERAPEUTICS LT's weight in each manager's 13F, not the share of Scinai Immunotherapeutics LT the manager owns.